SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001839882-22-012798
Filing Date
2022-06-09
Accepted
2022-06-09 09:06:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS cagm-defa14a_060722.htm DEFA14A 1769876
2 GRAPHIC centessa_defa14aimg001.gif GRAPHIC 13158
3 GRAPHIC centessa_defa14aimg002.gif GRAPHIC 176001
4 GRAPHIC centessa_defa14aimg003.gif GRAPHIC 44638
5 GRAPHIC centessa_defa14aimg004.gif GRAPHIC 131396
6 GRAPHIC sig-img01.jpg GRAPHIC 3769
7 GRAPHIC sig-img02.jpg GRAPHIC 3134
  Complete submission text file 0001839882-22-012798.txt   2283729
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40445 | Film No.: 221005054
SIC: 2834 Pharmaceutical Preparations